We are live on ! Find out more
NA

Neuburgh Advisers Portfolio holdings

AUM $3.22B
1-Year Est. Return 3.74%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+3.74%
3 Year Est. Return
+55.12%
5 Year Est. Return
10 Year Est. Return
AUM
$3.1B
AUM Growth
+$107M
Cap. Flow
-$107M
Cap. Flow %
-3.44%
Top 10 Hldgs %
24.59%
Holding
919
New
36
Increased
560
Reduced
229
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.5M
2
FFIV icon
F5
FFIV
+$8.69M
3
TDOC icon
Teladoc Health
TDOC
+$7.64M
4
SHOP icon
Shopify
SHOP
+$7.07M
5
UAL icon
United Airlines
UAL
+$6.07M

Sector Composition

Rank Sector Weight
1 Technology 16.91%
2 Healthcare 16.45%
3 Financials 15.13%
4 Consumer Discretionary 12.04%
5 Industrials 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECOL
601
DELISTED
US Ecology, Inc.
ECOL
$321K 0.01%
4,352
+748
+21% +$52.6K
CTB
602
DELISTED
Cooper Tire & Rubber Co.
CTB
$320K 0.01%
11,322
+3,672
+48% +$105K
HOPE icon
603
Hope Bancorp
HOPE
$1.79B
$314K 0.01%
19,404
+1,870
+11% +$32.4K
CHS
604
DELISTED
Chicos FAS, Inc.
CHS
$314K 0.01%
36,210
+6,834
+23% +$60.8K
CNO icon
605
CNO Financial Group
CNO
$5.14B
$313K 0.01%
14,752
+2,368
+19% +$49.7K
CBM
606
DELISTED
Cambrex Corporation
CBM
$313K 0.01%
4,576
+1,276
+39% +$78.9K
AEL
607
DELISTED
American Equity Investment Life Holding Company
AEL
$312K 0.01%
8,832
+1,984
+29% +$71.7K
ALEX
608
DELISTED
Alexander & Baldwin
ALEX
$311K 0.01%
13,702
+3,026
+28% +$71.8K
SAGE
609
DELISTED
Sage Therapeutics
SAGE
$311K 0.01%
2,200
+1,760
+400% +$272K
MYGN icon
610
Myriad Genetics
MYGN
$270M
$310K 0.01%
6,736
+432
+7% +$19.2K
BG icon
611
Bunge Global
BG
$20.4B
$308K 0.01%
4,488
-2,312
-34% -$153K
STM icon
612
STMicroelectronics
STM
$46.7B
$307K 0.01%
16,762
GHC icon
613
Graham Holdings Company
GHC
$5.1B
$306K 0.01%
528
-44
-8% -$25K
CALY
614
Callaway Golf Company
CALY
$3.32B
$306K 0.01%
12,606
+2,970
+31% +$63.8K
MED icon
615
Medifast
MED
$109M
$302K 0.01%
1,364
+418
+44% +$84.7K
VG
616
DELISTED
Vonage Holdings Corporation
VG
$301K 0.01%
21,248
+5,168
+32% +$71.1K
JEF icon
617
Jefferies Financial Group
JEF
$12.6B
$300K 0.01%
15,264
-69,852
-82% -$1.46M
GBCI icon
618
Glacier Bancorp
GBCI
$6.42B
$299K 0.01%
6,944
+1,296
+23% +$56.4K
TGNA
619
DELISTED
TEGNA Inc
TGNA
$298K 0.01%
24,928
+3,584
+17% +$40.7K
INN
620
Summit Hotel Properties
INN
$746M
$295K 0.01%
21,828
+3,264
+18% +$44.9K
GSK icon
621
GSK
GSK
$104B
$294K 0.01%
5,862
WDR
622
DELISTED
Waddell & Reed Financial, Inc.
WDR
$293K 0.01%
13,816
+2,772
+25% +$55.8K
ABCB icon
623
Ameris Bancorp
ABCB
$5.85B
$290K 0.01%
6,336
+1,628
+35% +$80.7K
FMBI
624
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$286K 0.01%
10,768
+960
+10% +$25.7K
VMI icon
625
Valmont Industries
VMI
$9.3B
$281K 0.01%
2,032
+304
+18% +$42.8K

Similar funds

Neuburgh Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Neuburgh Advisers held 919 positions worth $3.1B, up 3.6% from $3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Neuburgh Advisers withdrew a net $107M in Q3 2018, closing 31 positions and reducing 229 holdings. Its most notable exit was Goldman Sachs ActiveBeta Japan Equity ETF, an estimated $4.35M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Neuburgh Advisers opened a new position in VICI Properties worth $1.49M.

  • Neuburgh Advisers's largest Q3 2018 buy was VICI Properties: 69,072 shares worth $1.49M.
  • Neuburgh Advisers added most to Merck in Q3 2018, an estimated $26.5M increase.
  • Neuburgh Advisers's biggest Q3 2018 reduction was Valero Energy, cutting an estimated $15.4M.
  • Neuburgh Advisers fully exited Goldman Sachs ActiveBeta Japan Equity ETF in Q3 2018, selling an estimated $4.35M.
  • Neuburgh Advisers's ten largest holdings make up 25% of its $3.1B portfolio in Q3 2018.
  • Neuburgh Advisers opened 36 new positions and closed 31 in Q3 2018.
  • Neuburgh Advisers's portfolio value rose 3.6% quarter-over-quarter to $3.1B.

Based on Neuburgh Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.